Cardiovascular

Featured Article
How Do We Achieve Optimal Population Cardiovascular Health?
Mark Munger, PharmD, professor, Pharmacotherapy and Internal Medicine, University of Utah, discusses the declining rate of cardiovascular health across the world, and highlights what pharmacists can do in order to help support the 2020 goals set by the American Heart Association.
Update on Hypertension Epidemiology and Treatment for 2021
Mark Munger, PharmD, discusses recent hypertension research and explains why treatment is important for intensive blood pressure control.
Reducing Cardiology Malpractice Claims, Lawsuits in Health Practices
David L Feldman, MD, MBA, FACS, chief medical officer for The Doctors Company and for the TDC Group of companies, and John Preston Erwin, MD, cardiologist at NorthShore Medical Group, discuss a…

Newsfeed

How Do We Achieve Optimal Population Cardiovascular Health?
Update on Hypertension Epidemiology and Treatment for 2021
Reducing Cardiology Malpractice Claims, Lawsuits in Health Practices
Cost-Effectiveness of Implantable Loop Recorder Monitoring After Stroke in Line Wth Other Therapies
Postacute Care Spending by Hospital Varies Widely After Cardiac Surgery
Increased Health Care Utilization, Expenses in Patients With Tricuspid Regurgitation, Heart Failure
Value-Based Payments for Cardiovascular Care Yielding Mixed Results
Identifying the Important Role Pharmacists Play Among Patients Delaying PCP Care During the Pandemic
View More

Insights

How Do We Achieve Optimal Population Cardiovascular Health?
Mark Munger, PharmD, professor, Pharmacotherapy and Internal Medicine, University of Utah, discusses the declining rate of cardiovascular health across the world, and highlights what pharmacists can do in order to help support the 2020 goals set by…
Update on Hypertension Epidemiology and Treatment for 2021
Mark Munger, PharmD, discusses recent hypertension research and explains why treatment is important for intensive blood pressure control.
Reducing Cardiology Malpractice Claims, Lawsuits in Health Practices
David L Feldman, MD, MBA, FACS, chief medical officer for The Doctors Company and for the TDC Group of companies, and John Preston Erwin, MD, cardiologist at NorthShore Medical Group, discuss a recent study that examined diagnostic cardiology claims…
Identifying the Important Role Pharmacists Play Among Patients Delaying PCP Care During the Pandemic
Andrea Russo, MD, director, Electrophysiology and Arrhythmia Services, Cooper Hospital, discusses why there have been delays among patients making primary care visits, along with the impact this has on diagnosis, and she provides tips for health…
View More

Interactive Features

CV Deaths, Hospitalizations Reduced for Patients Treated With Farxiga
In this episode of PopHealth Perspectives, Kiersten Combs, vice president, US Cardiovascular and Metabolic Disease (US CVMD) and Naeem Khan, MD, vice president, medical, US CVMD, AstraZeneca, discuss the recent approval of Farxiga (dapagliflozin),…
Reducing Major Bleeding, CVD-Associated Deaths With Edoxaban
Robert Giugliano, MD, cardiovascular medicine specialist at Brigham and Women's Hospital, discusses the results of the ENGAGE AF-TIMI 48 trial explaining the benefits of treating patients with edoxaban, and why he encourages health care…
Mortality Rates Lowered Among NH Residents Receiving Statins as Secondary Prevention
According to study findings, older adults receiving statins after acute myocardial infarction experienced reduced 1-year mortality by what percent?
Adherence Rates Among Patients With AF Who Began Anticoagulation Therapy
Among those who receive oral anticoagulation therapy, researchers were curious about the following question: “What are the longitudinal patterns of adherence to treatment with warfarin and direct oral anticoagulants among patients with atrial…
View More
Back to Top